HC Wainwright Issues Negative Estimate for BCTX Earnings
BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) – Equities research analysts at HC Wainwright cut their Q3 2025 earnings estimates for BriaCell Therapeutics in a report released on Tuesday, April 22nd. HC Wainwright analyst E. Bodnar now expects that the company will post earnings per share of ($1.76) for the quarter, down from their previous […]
